# Efficacy of Vitamin C on AKI Outcomes in Critically Ill Cirrhotics With Multidrug-resistant Bacterial Infections.

> **NCT04494451** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 100 (actual)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** Vit C
- **DRUG:** Standard medical Treatment

## Key facts

- **NCT ID:** NCT04494451
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-15
- **Primary completion:** 2022-11-02
- **Final completion:** 2022-11-02
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04494451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04494451, "Efficacy of Vitamin C on AKI Outcomes in Critically Ill Cirrhotics With Multidrug-resistant Bacterial Infections.". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT04494451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*